Challenges and opportunities for enhancing biotechnology and technology transfer in developing countries

Biotechnology Advances

Volumn 24, Issue 1, 2006, Pages 69-79

  Salicrup, Luis A ^a   Fedorková, Lenka ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Biomedical innovation; Capacity building; Developing countries; International partnerships; License strategies; Neglected diseases; Technology transfer

Indexed keywords

BIOMEDICAL ENGINEERING; DEVELOPING COUNTRIES; DISEASE CONTROL; DRUG PRODUCTS; INTERNATIONAL COOPERATION; TECHNOLOGY TRANSFER;

BIOMEDICAL INNOVATION; CAPACITY BUILDING; INTERNATIONAL PARTNERSHIPS; LICENSE STRATEGIES; NEGLECTED DISEASES;

BIOTECHNOLOGY;

BIOTECHNOLOGY; DEVELOPING WORLD; HEALTH CARE; TECHNOLOGY TRANSFER;

BIOTECHNOLOGY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; ECONOMICS; HEALTH; LEGAL ASPECT; LICENSING; REVIEW; TECHNOLOGY;

BIOTECHNOLOGY; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; LICENSURE; TECHNOLOGY TRANSFER; WORLD HEALTH;

EID: 28244495120     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2005.06.004     Document Type: Review

References (52)

1. B. Abdelgafar, H. Thorsteindottir, U. Quach, P.A. Singer, and A.S. Daar The emergence of Egyptian biotechnology from genetics Nat Biotechnol 22 Supplement 2004 25 30 [Dec. 2004]
2. N. Ariffin, and M. Bell Firms, politics and political economy: patterns of subsidiary-parent linkages and technological capability building in electronics TNC subsidiaries in Malaysia K.S. Jomo G. Felker R. Rasiah Industrial technology development in Malaysia 1999 Routledge UK
3. Boulet P, Garrison C, 't Hoen E. Drug Patents Under the Spotlight: Sharing Practical Knowledge About Pharmaceutical Patents, Medicins Sans Frontiers, May 2003 Report, SRO-Kundig, Geneva.
4. CIPR Integrating intellectual property rights and development policy Commission on intellectual property rights 2001 DFID London http://www. iprcommission.org
5. CMH Commission on Macro Economics and Health (CMH) of the World Health Organization (WHO): macroeconomics and health: investing in health for economic development Report of the commission of macroeconomics and health 2001 http://www.cmhealth.org
6. A.S. Daar, H. Thorsteindsdottir, D.K. Martin, A.C. Smith, S. Nast, and P.A. Singer Top 10 biotechnologies for improving health in developing countries Nat Genet 32 2 2002 229 232
7. J.A. Di Masi, R.W. Hanson, H.G. Grabowski, and L. Lasagna Cost of innovation in the pharmaceutical industry J Health Econ 10 1991 107 142
8. DNDi Working Group and MSF. 2003. Intensified Control of Neglected Diseases: WHO Report of an International Workshop. Berlin, December 10-12, 2003. www.who.int/lep.
9. Ernst and Young. 2000. Management and Evaluation of Patents and Trademarks. Consultants' Analysis Report for the Danish Patent and Trademark Office, December 2000. Ernst and Young: http://www.European-patent-office.net.
10. R.E. Evenson, and L.E. Westphal Technological change and technology strategy J. Behrman T.N. Srinivasan Handbook of development economics vol. 3 1995 Elsevier Science B.V. The Netherlands 2209 2299
11. Falconi, C, Salazar, S, 1999. Identifying the Needs for Managing Intellectual Property In Latin America. Workshop Report, Costa Rica, 23-24 September 1999. ISNAR: The Hague.
12. Federal Register 2004a. Vol. 69, pp.57335-57336 (Sept. 24).
13. Federal Register 2004b. Vol 69, pp. 34381-34382 (June 21).
14. M. Ferrer, H. Thorsteindottir, U. Quach, P.A. Singer, and A.S. Daas The scientific muscle of Brazil's health biotechnology Nat Biotechnol 22 2004 8 12 [Dec. 2004]
15. C. Gardner, and C. Garner Technology licensing to nontraditional partners 2004 MIHR Publications
16. Global Forum for Health Research 2004. Mexico Forum 2004: Global Forum for Health Research: Helping Correct the 10/90 Gap. Mexico City, November 16-20, 2004. www.globalforumhealth.org.
17. D.R. Gwatkin, and M. Guillot The burden of disease among the global poor: current situation, future trends, and implications for research and policy Health, nutrition and population series 2000 The World Bank Washington, DC
18. R. Hirschberg, J. La Montagne, and A.S. Fauci Biomedical research - an integral component of national security N Engl J Med 350 21 2004 2119 2121
19. Hoekman, B, Maskus, K, and Saggi, K. 2004. Transfer of Technology to Developing Countries: Unilateral and Multilateral Policy Options. Working Paper No. 3332. The World Bank: Washington DC.
20. Interacademy Council Inventing a better future a strategy for building worldwide capacities in science and technology 2004 Inter Academy Council Amsterdan, The Netherlands http://www.interacademycouncil.net
21. C. Juma, and N. Clark Technological catch-up: opportunities and challenges for developing countries www.supra.ed.ac.uk/Publications/Paper_28.pdf 2002
22. C. Juma, K. Fang, D. Honca, J. Huete-Perez, V. Konde, and S.H. Lee Global governance of technology: meeting the needs of developing countries Int J Technol Manag 22 7/8 2001 629 655
23. H. Kettler Narrowing the gap between provision and need for medicines in developing countries 2000 Office of Health Economics (OHE) London
24. N.K. Kumar, U. Quach, H. Thorsteinsdottir, H. Somsekhar, A.S. Daar, and P.A. Singer Indian biotechnology-rapidly evolving and industry led Nat Biotechnol 22 2004 DC31 DC36 [Dec. 2004]
25. A. Marshall Open secrets Nat Biotechnol 22 Supplement 2004 1 [Dec. 2004]
26. Maskus, K. 2003. Transfer of Technology and Technological Capacity Building. ICTSD-UNCTAD Dialogue. 2nd Bellagio Series on Development and Intellectual Property. 18-21 Sept. 2003. http://www.ictsd.org/pubs/dloguepapers. htm.
27. K. Maskus Encouraging international technology transfer Intellectual property rights and sustainable development 2004 UNCTAD-ICTSD Geneva May 2004
28. S.M. Maurer, A. Rai, and A. Sali Finding cures for tropical diseases: is open source an answer? PLoS Med 1 3 2004 180 183 [Dec. 2004]
29. MVI Malaria Vaccine Initiative 2004 Backgrounder - accelerating vaccine development to save lives 2004 Malaria Vaccine Initiative Bethesda, MD http://www.malariavaccine.org/ab-ov2-compellingneed.htm
30. OECD. Conference on Biotechnology for Infectious Diseases: Addressing the Global Needs. Rapporteurs' Report. Lisbon, October 7-9, 2002.
31. OECD. Conference on Biotechnology for Infectious Diseases: Addressing the Global Needs Rapporteurs' Report (2003), http://www.oecd.org/dataoecd/53/20/ 2500434.pdf.
32. OECD Report. Organization for Economic Co-Operation and Development (OECD) Annual Report. Paris, France; 2004. http://www.oecd.org/dataoecd/28/49/ 31621929.pdf.
33. P. Olliaro, and P. Trouiller Drug development output: what proportion for tropical diseases? Lancet 354 1999 http://www.accessmed-msf.org/prod/ publications.asp?scntid=3082001227213&contenttype=PARA&
34. M. Rimmer The race to patent the SARS virus: the TRIPS agreement and access to essential medicines Melbourne J Int Law 5 2 2004 335 374 [October 2004]
35. K.G. Rivette, and D. Kline Rembrandts in the attic: unlocking the hidden value of patents 2000 Harvard Business School Press Boston MA
36. P. Romer Idea gaps and object gaps in economic development J Monet Econ 32 1993 531 555
37. Saha, R, Satyanarayana, K, Gardner, CA, 2004. Building a "Cottage Industry" for health (and wealth) the new framework for IP management in India. IP Strategy Today No. 10-2004. 23-58. www.bioDevelopments.org/ip.
38. L.A. Salicrup, and M.L. Rohrbaugh Partnerships in technology transfer - an innovative program to enhance biomedical and global health Int J Microbiol 8 1 2005 1 3 [March 2005]
39. L.A. Salicrup, R.F. Harris, C. Gardner, and M.L. Rorhbaugh Developing health R & D systems: partnerships for capacity building in international technology transfer Global forum for health research, Mexico City 2004
40. Salicrup, LA, Harris, RF, Rohrbaugh, ML, 2005. Partnerships in technology transfer: An innovative program to move biomedical and health technologies from the laboratory to worldwide application. IP Strategy Today, No. 12-2005. pp. 1-15.
41. W.D. Savedoff, and T.P. Schultz Wealth from health: linking social investments to earnings in Latin America 2000 Inter-American Development Bank Washington, D.C.
42. TB Alliance. 2003/2004 Annual Report. Global Alliance for TB Drug Development. New York City, NY 2004. www.tballiance.org.
43. TDR 2003. Tropical Disease Research Sixteenth Programme Report: Progress 2001-2002. In: Mattock N, editor. World Health Organization on behalf of the Special Programme for Research and Training in Tropical Diseases. Geneva, Switzerland: 2003. http://www.who.int/tdr.
44. H. Thorsteinsdotir, U. Quach, D.K. Martin, A.S. Daar, and P.A. Singer Introduction: promoting global health through biotechnology Nat Biotechnol 22 Supplement 2004 3 7 [Dec. 2004]
45. P. Trouiller, P. Olliaro, E. Toreele, J. Orbinski, R. Laing, and N. Ford Drug development for neglected diseases: a deficient market and a public-health policy failure The Lancet 359 2002 2188 2194
46. UNCTAD. 2003. UNCTAD's Commission on Science and Technology for Development (CSTD). Papers, workshops and meetings of the 6th session 2003. http://stdev.unctad.org/un/6thsession.html.
47. H. Varmus, R. Klausner, E. Zerhouni, T. Acharya, A.S. Daar, and P.A. Singer Grand challenges in global health Science 302 5644 2003 398 399
48. WHO, 2003. Intensified Control of Neglected Diseases: Report of an International Workshop, Berlin, 10-12 December 2003. World Health Organization, Geneva, Switzerland.
49. WHO Report. World Health Organization Report: Changing History. Geneva, Switzerland; 2004. http://www.who.int/whr/2004/en/index.html.
50. WHO-UNICEF. Global leaders intensify commitment to prevent leading childhood killer - measles. Cape Town, 17 October 2003 Meeting.
51. WIPO WIPO program and budget: cooperation with developing countries 2004 World Intellectual Property Organization 87 100 http://www.wipo.int/cfd/en/
52. E. Zerhouni The NIH Roadmap Science 302 5642 2003 63 72